Fairfield Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Fairfield Financial Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-168	Closed	-$87.2K	–	186
2024 Q4	$87.2K	Hold	168	–	–	0.03%	91
2024 Q3	$104K	Buy	168 +1	+0.6%	+$592	0.04%	97
2024 Q2	$92.6K	Buy	+167	New	+$95.7K	0.03%	98
2023 Q4	$94.2K	Hold	177	–	–	0.04%	105
2023 Q3	$89.8K	Hold	177	–	–	0.04%	100
2023 Q2	$92.5K	Hold	177	–	–	0.04%	101
2023 Q1	$99.8K	Hold	177	–	–	0.04%	98
2022 Q4	$97.6K	Hold	177	–	–	0.04%	93
2022 Q3	$89.9K	Hold	177	–	–	0.04%	93
2022 Q2	$96.2K	Hold	177	–	–	0.04%	84
2022 Q1	$105K	Buy	+177	New	+$102K	0.04%	82

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fairfield Financial Advisors's TMO Position: Q1 2025 in Review

Fairfield Financial Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 168 shares — an estimated $87.2K sold.

Fairfield Financial Advisors first reported a position in TMO in Q1 2022 and held it in 11 quarters. The position peaked at $105K in Q1 2022. 2,578 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

Fairfield Financial Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
Fairfield Financial Advisors sold 168 Thermo Fisher Scientific shares in Q1 2025, an estimated $87.2K.
Fairfield Financial Advisors first reported a position in Thermo Fisher Scientific in Q1 2022 and held it in 11 quarters.
Fairfield Financial Advisors's Thermo Fisher Scientific position peaked at $105K in Q1 2022.
2,578 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Fairfield Financial Advisors's 13F filing for Q1 2025, filed 9 May 2025.